HomeNKTR • NASDAQ
add
Nektar Therapeutics
Previous close
$1.33
Day range
$1.32 - $1.42
Year range
$0.41 - $1.93
Market cap
249.73M USD
Avg Volume
2.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 21.64M | 0.21% |
Operating expense | 47.56M | -7.75% |
Net income | -36.80M | 73.14% |
Net profit margin | -170.07 | 73.20% |
Earnings per share | -0.18 | 26.40% |
EBITDA | -32.84M | 5.38% |
Effective tax rate | 0.10% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 289.24M | -36.69% |
Total assets | 396.01M | -29.50% |
Total liabilities | 269.31M | -16.07% |
Total equity | 126.70M | — |
Shares outstanding | 183.62M | — |
Price to book | 1.93 | — |
Return on assets | -21.69% | — |
Return on capital | -23.92% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -36.80M | 73.14% |
Cash from operations | -47.89M | 7.76% |
Cash from investing | 19.26M | -52.56% |
Cash from financing | 42.00M | — |
Net change in cash | 13.36M | 218.57% |
Free cash flow | -20.09M | -17.35% |
About
Founded
1990
Headquarters
Website
Employees
137